TNDM Stock Analysis: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$19.50
0.49 (2.58%)
▲
5d:
+13.9%
30d:
+23.81%
90d:
-0.13%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: TNDM is 10.4% above its trading range ($17.66). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: TNDM is 10.4% above its trading range ($17.66). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $19.50, which is considered extended relative to its 30-day fair value range of $15.01 to $17.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 182.8) compared to its historical average (239.6). Remarkably, the market is currently pricing in an annual earnings decline of 8.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is approaching resistance at $19.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TNDM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.52 (+46.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is approaching resistance at $19.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TNDM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.52 (+46.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$15.01 -
$17.66
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.3% below Wall St target ($28.52)
Trading Range Analysis
30-Day Trading Range
$15.01 -
$17.66
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$16.14
Resistance Level
$19.66
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
182.76
Wall Street Target
$28.53
(+46.3%)
Revenue Growth (YoY)
5.5%
Earnings Growth (YoY)
-37.0%
Profit Margin
-9.2%
Valuation Discount vs History
-8.6% cheaper
PE vs Historical
182.8 vs 239.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.6%
(market-implied from PE analysis)
1-Year Target
$17.82
(-9%)
2-Year Target
$16.29
(-17%)
3-Year Target
$14.89
(-24%)
3-Yr Target (if PE normalizes)
(PE: 183→240)
$19.52
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 182.8 to 239.6
Stabilization Target:
$25.57
(+31.1%)
PE Expansion Potential:
+31.1%
Share & Embed Analysis
Last updated: August 02, 2026 3:38 PM ET
Data refreshes hourly during market hours. Next update: 4:38 PM
Data refreshes hourly during market hours. Next update: 4:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark David Novara
SELL
187 shares
2026-03-17
Mark David Novara
SELL
2 shares
2026-03-05
Gilbert Ray Cisneros, Jr.
BUY
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 52 HOLD |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
